Anti-CD20 x Anti-CD22 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD20 and anti-CD22 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY